Amprion Announces Initial Close of a $15M Financing to Commercialize Groundbreaking Neurologic Diagnostics
SAN DIEGO (October 9, 2024) — Amprion, a global leader advancing diagnosis of neurodegenerative disorders through seed amplification testing, today announced the successful initial $6